Halo Pharma Executive Chairman Lee Karras says escalating equipment and component costs are the two biggest challenges facing parenteral/sterile drug product manufacturers. 

See what else he had to say about key market trends in this article from ContractPharma: https://loom.ly/nlL8Pw0